Bi-functional shrna targeting stathmin 1 and uses thereof
AssigneeGradalis, Inc.
InventorsDONALD RAO, JOHN J. NEMUNAITIS, NEIL SENZER
Life of this patent
Estimating the term…
Abstract
The present invention includes bifunctional shRNAs capable of reducing an expression of a Stathmin 1 gene; wherein at least one target site sequence of the bifunctional RNA molecule is located within the Stathmin 1 gene, wherein the bifunctional RNA molecule is capable of activating a cleavage-dependent and a cleavage-independent RNA-induced silencing complex for reducing the expression level of Stathmin 1.
Claims40
A bifunctional shRNAs capable of reducing an expression of a Stathmin 1 gene;
- wherein at least one target site sequence of the bifunctional RNA molecule is located within the Stathmin 1 gene, wherein the bifunctional RNA molecule is capable of activating a cleavage-dependent and a cleavage-independent RNA-induced silencing complex for reducing the expression level of Stathmin 1.
An expression vector comprising:
- a promoter;
- and
- a nucleic acid insert operably linked to the promoter,
- wherein the nucleic acid insert encodes one or more shRNA capable of inhibiting an expression of at least one target gene that is a Stathmin 1 gene via RNA interference;
- wherein the one or more shRNA comprise a bifunctional RNA molecule that activates a cleavage-dependent and a cleavage-independent RNA-induced silencing complex for reducing the expression level of Stathmin 1.
A therapeutic delivery system comprising:
- a therapeutic agent carrier;
- and
- an expression vector comprising a promoter and a nucleic acid insert operably linked to the promoter, the nucleic acid insert encoding one or more short hairpin RNA (shRNA) capable inhibiting an expression of a target gene sequence that is Stathmin 1 gene via RNA interference;
- wherein the one or more shRNA comprise a bifunctional RNA molecule that activates a cleavage-dependent and a cleavage-independent RNA-induced silencing complex for reducing the expression level of Stathmin 1.
A method to deliver one or more shRNAs to a target tissue expressing an Stathmin 1 gene comprising the steps of:
- preparing an expression vector comprising a promoter and a nucleic acid insert operably linked to the promoter that encodes the one or more shRNA, wherein the one or more shRNA comprise a bifunctional RNA molecule that activates a cleavage-dependent and a cleavage-independent RNA-induced silencing complex for reducing the expression level of Stathmin 1;
- combining the expression vector with a therapeutic agent carrier, wherein the therapeutic agent carrier comprises a liposome;
- and
- administering a therapeutically effective amount of the expression vector and therapeutic agent carrier complex to a patient in need thereof.
A method to inhibit an expression of a Stathmin 1 gene in one or more target cells comprising the steps of:
- selecting the one or more target cells;
- and
- transfecting the target cell with a vector that expresses one or more short hairpin RNA (shRNAs) capable of inhibiting an expression of a Stathmin 1 gene in the one or more target cells via RNA interference;
- wherein the one or more shRNA comprise a bifunctional RNA molecule that activates a cleavage-dependent and a cleavage-independent RNA-induced silencing complex for reducing the expression level of Stathmin 1.
A method of suppressing a tumor cell growth in a human subject comprising the steps of:
- identifying the human subject in need for suppression of the tumor cell growth;
- and
- administering an expression vector in a therapeutic agent carrier complex to the human subject in an amount sufficient to suppress the tumor cell growth, wherein the expression vector expresses one or more shRNA capable inhibiting an expression of a target gene that is Stathmin 1 in the one or more target cells via RNA interference;
- wherein the one or more shRNA comprise a bifunctional RNA molecule that activates a cleavage-dependent and a cleavage-independent RNA-induced silencing complex for reducing the expression level of the target gene;
- wherein the inhibition results in an apoptosis, an arrested proliferation, or a reduced invasiveness of the tumor cells.
Dependencies are inferred from the claim text.